Marie Bartenschlager
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.
Journal: International journal of cancer
Published: November 11, 2023
Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients.
Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients.
Journal: Journal of medical virology
Published: September 15, 2023
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
Journal: Transplantation
Published: January 09, 2023
Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
Journal: Journal of medical virology
Published: December 24, 2022
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid.
Journal: Frontiers in medicine
Published: May 31, 2022
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy.
Journal: Journal of clinical medicine
Published: February 08, 2022
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: February 04, 2022
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.
Journal: Frontiers in immunology
Published: December 20, 2021
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis.
Journal: Annals of the rheumatic diseases
Published: October 25, 2021
Last Updated: 09/26/2026